April 2014
Volume 55, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2014
Fluorescence Lifetime Characteristics in Four Different Mouse Models
Author Affiliations & Notes
  • Chantal Dysli
    Ophthalmology, University Hospital Bern, Bern, Switzerland
    Graduate School for Cellular and Biomedical Sciences, University of Bern, Bern, Switzerland
  • Muriel Dysli
    Ophthalmology, University Hospital Bern, Bern, Switzerland
    Graduate School for Cellular and Biomedical Sciences, University of Bern, Bern, Switzerland
  • Volker Enzmann
    Ophthalmology, University Hospital Bern, Bern, Switzerland
  • Sebastian Wolf
    Ophthalmology, University Hospital Bern, Bern, Switzerland
  • Martin Sebastian Zinkernagel
    Ophthalmology, University Hospital Bern, Bern, Switzerland
  • Footnotes
    Commercial Relationships Chantal Dysli, Heidelberg Engineering (F); Muriel Dysli, None; Volker Enzmann, None; Sebastian Wolf, Heidelberg Engineering (C), Heidelberg Engineering (F); Martin Zinkernagel, Allergan (F), Bayer (C), Heidelberg Engineering (F), Novartis (F), Novartis (I)
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 2089. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Chantal Dysli, Muriel Dysli, Volker Enzmann, Sebastian Wolf, Martin Sebastian Zinkernagel, Ophthalmology, University Hospital Bern; Fluorescence Lifetime Characteristics in Four Different Mouse Models. Invest. Ophthalmol. Vis. Sci. 2014;55(13):2089.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: Fluorescence Lifetime Imaging Ophthalmoscopy (FLIO) is an imaging technique that allows non-invasive in vivo measurement of fluorescence lifetimes of natural fluorophores in the retina after excitation with picosecond laser pulses. We address to characterize fluorescence lifetimes in four different mouse strains in order to gain basic information about natural fluorophores of their retina.

Methods: Fluorescence lifetime imaging is performed using a Fluorescence Lifetime Imaging Ophthalmoscope (FLIO) based on a Heidelberg Engineering Spectralis® system. The fluorescence excitation wavelength was 473 nm and decay times were measured in a short and in a long spectral channel (SSC: 498-560 nm and LSC: 560-720 nm resp.) Four different strains of mice were examined: pigmented (C57BL/6), non-pigmented (BALBc) and CX3CR1GFP+ mice, and a mouse model of retinal degeneration (RDS; C3A.Cg-Pde6b + Prph2Rd2/J). Corresponding OCT-images (optical coherence tomography) were acquired.

Results: Fluorescence lifetime measurement was highly specific and reproducible for each mouse strain with coefficients of variation of 2 to 15% in the short (SSC) and 10 to 25% in the long spectral channel (LSC). CX3CR1GFP+ mice showed the most distinct lifetime values in both spectral channels with the biggest standard deviation. In both spectral channels, mean lifetime (Tm) was the longest in CX3CR1GFP+ mice (SSC: Tm=1925 picoseconds (ps), LSC: Tm = 518 ps). In the short spectral channel, CX3CR1GFP+ mice were followed by pigmented (Tm = 956 ps), RDS (Tm = 883 ps) and non-pigmented mice (Tm = 801 ps). In the long spectral channel, Tm was similar in pigmented (Tm = 290 ps) and RDS-mice (Tm = 288 ps), followed by non-pigmented mice with the shortest Tm (Tm = 241 ps).

Conclusions: Fluorescence lifetime values differ between the mouse strains with little variance within the groups. GFP marked areas lead to distinct fluorescence lifetimes. These are promising results for further analysis of fluorescence lifetime characteristics in mouse models to identify the contribution of different structural and metabolic states in the murine retina.

Keywords: 551 imaging/image analysis: non-clinical • 688 retina • 552 imaging methods (CT, FA, ICG, MRI, OCT, RTA, SLO, ultrasound)  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×